Your browser doesn't support javascript.
loading
Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review.
Solomon, Sharon D; Lindsley, Kristina B; Krzystolik, Magdalena G; Vedula, Satyanarayana S; Hawkins, Barbara S.
Afiliação
  • Solomon SD; Wilmer Eye Institute, School of Medicine, The Johns Hopkins University, Baltimore, Maryland.
  • Lindsley KB; Department of Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.
  • Krzystolik MG; Retina Service, Massachusetts Eye and Ear Infirmary, Providence, Rhode Island.
  • Vedula SS; The Johns Hopkins University, Baltimore, Maryland.
  • Hawkins BS; Wilmer Eye Institute, School of Medicine, The Johns Hopkins University, Baltimore, Maryland; Department of Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland. Electronic address: bhawkins@jhmi.edu.
Ophthalmology ; 123(1): 70-77.e1, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26477843
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acuidade Visual / Neovascularização Retiniana / Bevacizumab / Ranibizumab / Degeneração Macular Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acuidade Visual / Neovascularização Retiniana / Bevacizumab / Ranibizumab / Degeneração Macular Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article